Coeptis Therapeutics Warrants
COEPW
COEPW was delisted on the 24th of April, 2026.
11 hedge funds and large institutions have $14.9K invested in Coeptis Therapeutics Warrants in 2025 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 3 closing their positions.
15% less funds holding
Funds holding: 13 → 11 (-2)
27.02% less ownership
Funds ownership: 27.02% → 0% (-27%)
41% less capital invested
Capital invested by funds: $25.1K → $14.9K (-$10.2K)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
75% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$266 |
| 2 |
CS
Clear Street
New York
|
+$127 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MC
Meteora Capital
Boca Raton,
Florida
|
-$3.57K |
| 2 |
CF
Cantor Fitzgerald
New York
|
-$3.07K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.57K |
| 4 |
Walleye Trading
New York
|
-$1.33K |
| 5 |
TSS
Two Sigma Securities
New York
|
-$748 |
COEPW Hedge Fund Activity: Q3 2025 in Review
11 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in Coeptis Therapeutics Warrants (COEPW) for Q3 2025, worth a combined $14.9K — down 41% from $25.1K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of COEPW and 1 opened new positions — a net loss of 2 holders — while 4 trimmed existing stakes and 1 added.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $266. The largest seller was Meteora Capital, cutting an estimated $3.57K.
- 11 institutional investors held Coeptis Therapeutics Warrants (COEPW) as of Q3 2025, down from 13 in Q2 2025.
- Funds reported $14.9K of Coeptis Therapeutics Warrants stock for Q3 2025, down 41% quarter-over-quarter.
- 1 fund opened new Coeptis Therapeutics Warrants positions in Q3 2025 and 3 closed out, a net change of -2 holders.
- The largest Coeptis Therapeutics Warrants buyer in Q3 2025 was Citadel Advisors, an estimated $266 added.
- The largest Coeptis Therapeutics Warrants seller in Q3 2025 was Meteora Capital, an estimated $3.57K sold.
Based on aggregated 13F filings for Q3 2025.